Incorporating Patient Input into the Target Product Profile

Area of Science:

• Drug development and regulatory science
• Patient-centered research methodologies
• Health outcomes research

Background:

• Target Product Profiles (TPPs) guide drug development but often lack comprehensive patient input.
• Patient perspectives are crucial for defining treatment success and market viability.
• Existing TPP development processes may not systematically integrate patient expertise.

Purpose of the Study:

• To develop a systematic guidance framework for creating patient-focused, standardized TPPs.
• To identify key areas within TPPs where patient perspectives are fundamental.
• To provide actionable recommendations for R&D organizations engaging with patient communities.

Main Methods:

• Iterative development of a guidance framework with patient community validation.
• Identification of five core TPP focus areas for patient input: target population, unmet need, dosage, efficacy endpoints, and benefit/risk.
• Review of tools for obtaining patient perspectives (e.g., advisory boards, interviews).

Main Results:

• A systematic guidance framework for patient-focused TPPs was developed.
• Five fundamental focus areas for patient input in TPPs were identified.
• Key requirements for effective R&D-patient representative interaction were highlighted, including clear language and respect.

Conclusions:

• Integrating patient perspectives early and systematically into TPPs is essential for successful drug development.
• A structured approach enhances the value of patient input, leading to better-aligned and approvable drug products.
• Empowering patient organizations to adapt these processes can amplify their influence in drug development.